Skip to main content

Renewal of GLP accreditation

We are pleased to share that Immune Analytics has successfully renewed its GLP certification following a GLP audit by LUBW (Landesanstalt für Umwelt Baden-Württemberg) in 2024, receiving an updated GLP Certificate in September 2024.

Founded in 1989 with headquarters in the south-west of Germany, AID produces and markets diagnostic products, imaging devices, and suitable software programs within a wide range of immunology and infectious diseases. AID is the developer and manufacturer of one of the most frequently used EliSpot readers worldwide, the AID EliSpot Reader System. In 2017, the AID group established Immune Analytics, a specialist CRO unit that focuses on customized development and validation of EliSpot/FluoroSpot assays for GLP and GCLP-compliant immunomonitoring of preclinical and clinical samples to quantify specific T and B cell responses.


Contact: info@immune-analytics.com
www.immune-analytics.com

elispot, fluorospot, GCLP, GLP, Immunemonitoring, news, preclinical

© GenID Genome Identification Diagnostics GmbH.
All rights reserved.

Immune Analytics Logo